Related references
Note: Only part of the references are listed.Position-specific oxidation of miR-1 encodes cardiac hypertrophy
Heeyoung Seok et al.
NATURE (2020)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019 Update From the GBD 2019 Study
Gregory A. Roth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Satoshi Umemura et al.
HYPERTENSION RESEARCH (2019)
Deciphering miRNAs' Action through miRNA Editing
Marta Correia de Sousa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
MicroRNA Key to Angiogenesis Regulation: miRNA Biology and Therapy
Ankit Tiwari et al.
CURRENT CANCER DRUG TARGETS (2018)
Hypertension, left ventricular hypertrophy, and sudden cardiac death
Mohammad Shenasa et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
MicroRNAs in Cardiovascular Disease
Temo Barwari et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia et al.
EUROPEAN HEART JOURNAL (2013)
Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice
Jian Wang et al.
CELL RESEARCH (2012)
Prevalence of left-ventricular hypertrophy in hypertension: an updated review of echocardiographic studies
C. Cuspidi et al.
JOURNAL OF HUMAN HYPERTENSION (2012)
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
Penny F. Whiting et al.
ANNALS OF INTERNAL MEDICINE (2011)
The widespread regulation of microRNA biogenesis, function and decay
Jacek Krol et al.
NATURE REVIEWS GENETICS (2010)
MicroRNAs: novel regulators in cardiac development and disease
Thomas Thum et al.
CARDIOVASCULAR RESEARCH (2008)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Therapeutic options in minimizing left ventricular hypertrophy
RB Devereux
AMERICAN HEART JOURNAL (2000)
Share Paper
